Larimar Therapeutics LRMR
NASDAQ LRMR
$3.19 +0.05 (+1.59%)
At close: Sep 30, 2026 · 4:00 PM EDT

Larimar Therapeutics (LRMR) Other Operating Expenses (2019 - 2020)

Updated

Larimar Therapeutics' Other Operating Expenses was -$10,000 in Q1 2020.

Analysis

Larimar Therapeutics (LRMR) Other Operating Expenses (2019 - 2020) Analysis & Trends

For FY2019, Other Operating Expenses at Larimar Therapeutics came in at -$5.55 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Larimar Therapeutics 331.39 Mn -275.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -10,000.00
Dec 31, 2019 -411,000.00
Sep 30, 2019 -4.02 Mn
API Access

Larimar Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=LRMR&period=max&api_key=YOUR_API_KEY